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Abstract
Parkinson disease (PD) involves progressive neurodegeneration, including loss of dopamine (DA) neurons from the
substantia nigra. Select genes associated with rare familial forms of PD function in cellular pathways, such as the ubiquitin-
proteasome system (UPS), involved in protein degradation. The misfolding and accumulation of proteins, such as a-
synuclein, into inclusions termed Lewy Bodies represents a clinical hallmark of PD. Given the predominance of sporadic PD
among patient populations, environmental toxins may induce the disease, although their nature is largely unknown. Thus,
an unmet challenge surrounds the discovery of causal or contributory neurotoxic factors that could account for the
prevalence of sporadic PD. Bacteria within the order Actinomycetales are renowned for their robust production of secondary
metabolites and might represent unidentified sources of environmental exposures. Among these, the aerobic genera,
Streptomyces, produce natural proteasome inhibitors that block protein degradation and may potentially damage DA
neurons. Here we demonstrate that a metabolite produced by a common soil bacterium, S. venezuelae, caused DA
neurodegeneration in the nematode, Caenorhabditis elegans, which increased as animals aged. This metabolite, which
disrupts UPS function, caused gradual degeneration of all neuronal classes examined, however DA neurons were particularly
vulnerable to exposure. The presence of DA exacerbated toxicity because neurodegeneration was attenuated in mutant
nematodes depleted for tyrosine hydroxylase (TH), the rate-limiting enzyme in DA production. Strikingly, this factor caused
dose-dependent death of human SH-SY5Y neuroblastoma cells, a dopaminergic line. Efforts to purify the toxic activity
revealed that it is a highly stable, lipophilic, and chemically unique small molecule. Evidence of a robust neurotoxic factor
that selectively impacts neuronal survival in a progressive yet moderate manner is consistent with the etiology of age-
associated neurodegenerative diseases. Collectively, these data suggest the potential for exposures to the metabolites of
specific common soil bacteria to possibly represent a contributory environmental component to PD.
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Introduction
Neurodegenerative diseases comprise a major societal burden
with increasing occurrence as our mean population age rises. The
interplay between genetic predisposition and susceptibility to
environmental insults lies at the core of onset and progression of
several neurological diseases. For example, PD is the second-most
common neurodegenerative disorder, afflicting millions of indi-
viduals worldwide. Over the course of the past decade, human
genetic discoveries have driven substantial mechanistic advances
in our understanding of PD [1]. Nevertheless, an inescapable fact
of PD epidemiology is that over 90% of cases are of sporadic
origin. Twin studies indicate that environmental influences are
critical to disease onset and appear pivotal to sporadic causality
[2]. Thus, while genetic analyses have substantially advanced our
mechanistic understanding of PD, it is apparent that investigation
into purely genetic factors will not elucidate all or even most PD
incidence. Therefore, our ability to successfully reduce the
frequency of PD is dependent upon knowledge about factors that
render certain populations at risk.
PD affects more than 1% of the population over age 65,
increasing to 4–5% in people 85-years of age. In addition to aging,
one of the few established epidemiological contributors to PD
appears to be a rural lifestyle. Analyses of various factors has
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7227revealed that living in rural areas, drinking well water, farming,
and exposure to pesticides or herbicides may all be risk factors for
developing PD [3,4]. Toxins that cause formation of excessive
reactive oxygen species, like paraquat and rotenone, as well as
MPTP, all induce Parkinsonian phenotypes in animals [5]. While
use of pesticides has been suggested to be partially responsible for
PD in rural areas, this does not sufficiently correlate to disease
prevalence, as the odds ratio for farming itself cannot be accounted
for by pesticide exposure alone [6,7].
Associated with rural living, individuals exhibit a much greater
interaction with the surrounding terrestrial environment, whether
by choice (e.g., occupation, avocation) or by necessity (e.g.,
drinking well water). A single gram of soil has been shown to
contain up to 1 billion microorganisms with a predicted maximum
of nearly 1 million individual microbial species. Within the order
Actinomycetales, the ubiquitous soil bacterial genus Streptomyces
contributes ,6% to this total [8]. These gram positive, aerobic,
organisms are responsible for producing greater than 70% of
known antibiotics, in addition to a suite of other metabolites,in-
cluding proteasome inhibitors. At least four characterized protea-
some inhibitors are products of streptomycetes isolated from soil,
including lactacystin. Impairment of the UPS as a contributory
factor to sporadic PD has been suggested by a variety of studies
[9]. We therefore hypothesized that enhanced exposure to these
bacteria may contribute to the onset or progression of PD.
Here we show that common soil bacteria of a distinct Streptomyces
species produce a secondary metabolite that causes neurodegen-
eration. Preliminary chemical characterization of the bacterial
factor indicates it is a small molecular weight compound that is
highly stable, hydrophobic, and chemically unique. Using a variety
of mutant and transgenic lines of worms we demonstrate that the
DA neurons of the nematode, C. elegans, exhibit enhanced
vulnerability to this bacterial metabolite in vivo. Likewise, while
other neuronal subclasses exposed to the toxin degenerated, these
did not die as rapidly as DA neurons. These data were extended to
human DA-producing neurons, where the bacterial metabolite
also exhibited dose-dependent toxicity. Taken together, this study
demonstrates that dopaminergic neurons are highly susceptible to
a secondary metabolite produced by a common soil Streptomyces
species, thereby suggesting the prospect that exposure to these
strains could potentially represent a previously unreported
environmental contributor to neurodegenerative disease.
Results
C. elegans DA neurodegeneration results from exposure
to S. venezuelae
When considering potential environmental sources of neuro-
toxicity associated with neurodegenerative disorders, we were
intrigued by reports that described DA neurodegeneration and
PD-like symptoms following direct injection of proteasome
inhibitors into rat brains [10,11]. This prompted us to initially
determine if exposure to proteasome inhibitors could cause
neurodegeneration in C. elegans. Worms expressing GFP specifi-
cally in DA neurons (Pdat-1::GFP) [12] were exposed to the
proteasome inhibitor MG-132 for a total of eight days and DA
neurodegeneration was scored every two days, as previously
described [13]. MG-132 caused a progressive loss of DA neurons
(Fig. 1); after eight days of exposure, 23% of worms displayed DA
degeneration compared with 3% of worms exposed to the DMSO
vehicle (P,0.001).
Since worms displayed DA neurodegeneration in response to a
purified proteasome inhibitor, we considered possible sources of
naturally occurring exposures. We therefore examined the potential
for secondary metabolites of common soil bacteria, Streptomyces
species (S. coelicolor, S. griseus, and S. venezuelae), to cause DA
neurodegeneration in C. elegans. Worms eat bacteria; E. coli is a
standard laboratory food source used to maintain C. elegans. Thus,
we initially attempted to directly expose these animals to Streptomyces
spp. through feeding. However, the nematodes displayed an
aversion behavior in response to Streptomyces spp. This is not
surprising since C. elegans display chemosensory avoidance of
unfamiliar bacteria [14]. We therefore grew each species in liquid
culture and subsequently tested the conditioned growth media for
neurodegenerative activity in C. elegans. Actinomycete metabolites
are typically produced by stationary phase bacteria, therefore
Streptomyces spp. were grown for two weeks in SYZ media (used for
metabolite production) [15,16] before cell removal and testing. E.
coli was also grown in liquid culture as a control.
Theconditionedbacterialmediawere incorporatedintostandard
worm growth media and animals were scored for evidence of
degenerativechangesto DA neurons. Worms grown in the presence
of S. venezuelae conditioned medium displayed significant and
increasing degenerative changes at four and six days of exposure
(Fig. 2A). For example, after six days of exposure to S. venezuelae
conditioned medium, 27% of worms displayed DA neurodegener-
ation. In contrast, only 6%, 7%, and 4% of worms exposed to S.
griseus, S. coelicolor,a n dE. coli media, respectively, contained
degenerating DA neurons (P,0.001) (Fig. 2A). While the worms
exposed to S. venezuelae medium exhibited DA neurodegenerative
changes and neuronal loss (Fig. 2B), the overall lifespan and
reproductive activity of these animals appeared unchanged. This
was not unexpected, as DA neurons are non-essential in C. elegans
and their loss results in only subtle behavioral changes [17].
Enhanced vulnerability of dopamine neurons to the S.
venezuelae factor
A distinct advantage of using C. elegans is the ability to discern
and quantify the precise cellular complement of specific neuronal
classes, permitting us to examine four other neuronal subclasses for
sensitivity to the S. venezuelae factor. These subtypes, serotonergic
(5-HT), GABAergic (GABA), cholinergic (ACh), and glutamater-
Figure 1. Neurodegeneration occurs in C. elegans following
exposure to the proteasome inhibitor MG-132. An isogenic worm
strain expressing GFP in DA neurons was examined for DA neurode-
generation every two days. Significant DA neurodegeneration occurred
after eight days of continuous exposure to MG-132 in comparison to
the solvent control (*P,0.05; ANOVA). All data in this figure are
represented as mean worms with neurodegeneration +/2 S.E.M.
doi:10.1371/journal.pone.0007227.g001
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specifically within these neurons using Ptph-1::GFP [18],
Punc-47::GFP [19], Punc-4::GFP [20] and Peat-4::GFP [21] reporter
constructs, respectively. While DA neurons showed significant
degeneration after four days of exposure to S. venezuelae
conditioned medium (Fig. 2A), other neuronal classes did not
exhibit significant degenerative changes at earlier ages, even at six
days of continuous exposure (Fig. 2C). Specifically, #5% of worms
displayed 5-HT, GABA, ACh, or Glut neurodegeneration,
compared with 22% of worms exhibiting DA neurodegeneration
at day six (P,0.01; data standardized with E. coli conditioned
medium control).
W h e nt h ee x p o s u r et oS. venezuelae conditioned medium was
extended to eight days, all neuronal classes exhibited some
degeneration, but the DA neurons were still preferentially vulnerable
compared to other neuronal classes (Fig. 2D) (P,0.05). Since worms
possess different numbers of neurons in the various neuronal classes
examined, comparative loss across different subtypes was represented
in Fig. 2D by the percentage of neurons scored within a given subclass
that were degenerating (instead of percentage of worms displaying at
least one degenerating neuron, as reported in Fig. 2C). With this
scoring method we found that, at eight days, 17% of the DA neuron
population was degenerated while only 5–10% of 5-HT, GABA, ACh,
and Glut neurons were degenerated (Fig. 2D). The non-dopaminergic
neuronal classes all exhibited significant degeneration following eight
days of exposure in comparison to the amount of degeneration
exhibited after six days exposure (P,0.01 for these neuronal classes).
These data demonstrate that continuous exposure to S. venezuelae
metabolites causes progressive degeneration across different C. elegans
neuronal subtypes and that DA neurons exhibit both an accelerated
and enhanced vulnerability to the degenerative effect.
The anatomical placement of the different neuronal subtypes
within the intact nematode body plan may partially account for
differential access of toxin to select neurons. Moreover, it is
possible that the C. elegans cuticle impedes entry of the S. venezuelae
metabolite in vivo. Therefore, we generated primary cultures of
distinct C. elegans neuron subtypes to determine if significant
enhancement in degeneration of various neuronal subtypes occurs
in vitro. A modest increase in the effect of the S. venezuelae
metabolite was observed, with the degeneration of 10% of GABA
neurons (vs. 6% in vivo) and 15% ACh neurons scored (vs. 7% in
vivo) (Fig. 3A). However, as described below, DA neurons exhibited
a much higher enhancement in degeneration when cultured.
Thus, it appears that the cuticle might provide a partial barrier
from the degenerative factor, but that DA neurons still retain their
selective vulnerability when cultured, suggesting that an intrinsic
factor within DA neurons is associated with enhanced degener-
ation (Fig. 2C, 2D vs. 3A ).
The presence of dopamine exacerbates
neurodegeneration
Some DA toxins, such as 6-hydroxydopamine (6-OHDA), are
selective because they are substrates for the DA transporter (DAT).
To explore the possibility that the C. elegans DA transporter, DAT-
1 might facilitate entry of the S. venezuelae factor, dat-1 mutant
worms expressing GFP in DA neurons (dat-1;P dat-1::GFP), which
are deficient for DAT-1 [13,22], were examined for neurodegen-
eration in response to the factor. After six days of exposure to S.
venezuelae conditioned medium there was no significant difference
in DA neurodegeneration between WT and dat-1 worms
(2461.3% vs. 2964.4% worms with DA neurodegeneration,
respectively). We therefore conclude that the neurotoxic S.
venezuelae metabolite is not specifically entering DA neurons
through the DAT-1 transporter.
Since DA neurons degenerate more readily than other neuronal
classes, we hypothesized that the presence of DA itself might
enhance the neurodegeneration associated with exposures. To
examine this, we exposed cat-2 (e1112) mutant worms [23] to S.
venezuelae conditioned medium. cat-2 worms express reduced levels
of TH, the rate-limiting enzyme in the production of DA, and as a
Figure 2. Neurodegeneration occurs in C. elegans following exposure to S. venezuelae conditioned medium. A. An isogenic worm strain
expressing GFP in DA neurons was examined for DA neurodegeneration four and six days after exposure to Streptomyces spp. conditioned media.
Significant DA neurodegeneration only occurred from exposure to S. venezuelae conditioned medium (*P,0.05; ANOVA). B. Photomicrographs of
GFP-labeled DA neurons from C. elegans exposed to bacterial conditioned medium for six days. All six anterior DA neurons in C. elegans exhibit
degenerative changes following exposure to S. venezuelae but not E. coli (control) medium (the four CEP class of DA neurons and the two ADE class of
DA neurons are indicated with arrows and arrowheads, respectively). C. Populations of isogenic worm strains expressing GFP exclusively in 5-HT,
GABA, ACh, Glut, and DA (+ and –TH) neuronal classes were examined for neurodegeneration. The only animals that displayed significant
neurodegeneration after six days exposure to S. venezuelae conditioned medium were those in which the DA (+TH) neurons were analyzed (*P,0.01;
ANOVA). These data were standardized against the amount of degeneration observed from exposure to E. coli control conditioned medium. D. At
eight days of exposure to S. venezuelae conditioned medium, all neuronal classes examined exhibited significant degeneration (*P,0.01; ANOVA).
These data were standardized against the amount of degeneration observed from exposure to E. coli control conditioned medium. Because each
neuronal class contains varying numbers of neurons, this analysis was based on the percentage of degenerating neurons (not degenerating worms,
as in Fig. 1C) to compensate for differences in total neuron numbers. Furthermore, DA neurons still exhibited significantly more degeneration than
other neuronal classes (*P,0.05; ANOVA). All graphical data in this figure are represented as mean degeneration +/2 S.E.M. Scale bar=50 mM.
doi:10.1371/journal.pone.0007227.g002
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of exposure, populations of cat-2 worms (-TH) displayed substan-
tially less degeneration (1%) than wild-type worms with normal
levels of DA synthesis (22%) (P,0.001; Fig. 2C). Notably, when
examining the comparative loss of individual neurons after eight
days of exposure to S. venezuelae medium (Fig. 2D), only 3% of DA
(-TH) neurons within cat-2 worms exhibited DA neurodegeneration
compared with 17% of DA neurons in wild-type worms (P,0.01).
Therefore, the presence of DA appears to provide a sensitized
cellular milieu for the S. venezuelae factor that exacerbates
neurodegeneration.
We also examined the effect of the cat-2 mutant in vitro. Wild-
type and cat-2 mutant neurons were cultured in the presence of the
S. venezuelae factor and scored for rates of degeneration. The
percentage of degenerated neurons was standardized against E. coli
conditioned medium (where 0–1.5% of neurons degenerated).
Notably, in culture, DA neurons degenerate faster when exposed
to the S. venezuelae factor; strikingly, 100% of the wild-type DA
neuron population (+TH) displayed degenerative changes at day
five of continuous exposure while only 60% of the cat-2 DA
neurons (-TH) also displayed degenerative changes (Fig. 3B, 3C).
To determine if conditioned media from all three Streptomyces spp.
examined in our study could cause significant degeneration in
culture, wild-type DA neurons were exposed to S. griseus and S.
coelicolor conditioned media at the same concentration as S.
venezuelae (0.5%). No degeneration (0%) was observed in the
cultured DA neurons, even after five days of exposure. Thus, the
enhanced degenerative effect observed in DA neurons is highly
specific to the S. venezuelae factor.
The S. venezuelae neurodegenerative factor inhibits the
UPS
Several mechanisms associated with intracellular stress and
neurodegeneration could be influenced by the S. venezuelae factor.
For example, this toxin might trigger a generalized chaperone-
mediated stress response within C. elegans cells. HSP-16 is a C.
elegans homolog of the hsp16/hsp20/alphaB-crystallin family of
heat shock proteins. In Phsp-16::lacZ worms, expression of b-
galactosidase is driven by the hsp-16 promoter following exposure
to specific chemical or physical stressors [25,26]. To examine
whether the S. venezuelae metabolite activates small heat shock
proteins, Phsp-16::lacZ worms were exposed to E. coli and S.
venezuelae conditioned media (Fig. 4). Neither conditioned medium
induced significant b-galactosidase expression in Phsp-16::GFP
worms (Fig. 4A, C). In comparison, most worms exposed to an
established general stressor, CdCl2, expressed high levels of b-
galactosidase (P,0.001; Fig. 4A), which was evident within the
hypodermis (Fig. 4C). Worms were also treated with the
proteasome inhibitor MG-132, which did not induce significant
b-galactosidase expression (Fig. 4B, C).
The unfolded protein response (UPR) is another common
mechanism associated with cellular stress and PD [27]. We
examined the possibility that the S. venezuelae factor up-regulated
the UPR by exposing worms expressing an established UPR
reporter, Phsp-4::GFP, to conditioned medium [28]. C. elegans HSP-
4 is homologous to the mammalian ER chaperone, BiP, and its
transcription is prominently induced in the worm intestine in
response to ER stress. We determined that the S. venezuelae
neurodegenerative factor did not induce hsp-4, as higher levels of
hsp-4::GFP were observed in only 2% and 5% of worms exposed to
E. coli and S. venezuelae conditioned media, respectively (Fig. 5A, B).
In contrast, 68% of control animals exposed to an established
UPR-inducer, tunicamycin, exhibited robust hsp-4::GFP expres-
sion (P,0.001; Fig. 5A, B). Worms exposed to MG-132 displayed
an increased level of GFP fluorescence that was comparable to
tunicamycin (P=0.653; Fig. 5C, D). These data are consistent
with a previous study wherein canine kidney cells exposed to MG-
132 displayed increased BiP expression [29].
Another candidate cellular mechanism potentially modulated
by the S. venezuelae neurodegenerative factor is the UPS. We
adapted an in vivo fluorescence-based assay for proteasome
inhibition [30] by expressing a ubiquitination signal (CL-1, also
referred to a ‘‘degron’’) fused to CFP within the DA neurons of C.
elegans (Pdat-1:: CFP::CL-1). This CFP::CL-1 reporter functions as a
biomonitor for ubiquitin-related degradation whereby CFP
fluorescence levels are low when the protein is degraded (i.e.,
UPS is active) and the fluorescence much higher when the protein
is not degraded (UPS activity is functionally impaired). When CL-
1::CFP worms are exposed to MG-132, we observed a 25%
increase in DA neuron fluorescence in comparison to worms
exposed to the DMSO solvent (Fig. 6A). Notably, exposure to S.
venezuelae conditioned medium also resulted in a significant, 18%,
increase of CFP fluorescence when compared with worms exposed
to E. coli conditioned medium (P,0.05) (Fig. 6B). Based on our
initial mechanistic studies, the S. venezuelae toxin does not elicit a
generalized chaperone-mediated stress response or upregulate the
UPR, but it does block degron degradation. Therefore, we
Figure 3. C. elegans neurons cultured in vitro display enhanced levels of degeneration in response to exposure to S. venezuelae
conditioned medium. A. GABA neurons degenerate slowly in culture when compared to DA neurons. B. DA neurons degenerate rapidly in culture.
Almost all wild-type DA neurons (+TH) are degenerated after five days of continuous exposure to the conditioned medium. A substantial proportion
of DA neurons from cat-2 mutant worms (–TH) degenerate as well. C. Photomicrographs that capture the same DA neurons (+ and –TH) over the
course of several days exposure to the S. venezuelae factor. There is one less image for DA+ neurons because this neuron had degenerated by day
four and was not visible. Arrows depict degeneration in cell processes. All graphical data in this figure are represented as mean degeneration relative
to E. coli conditioned medium controls (control degeneration was always ,2%). Scale bar=5 mM.
doi:10.1371/journal.pone.0007227.g003
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neurotoxic activity that blocks the UPS.
Human DA cells are sensitive to the S. venezuelae factor
While the nematode model is an excellent system that can
provide preliminary toxicological and mechanistic insights,
ultimately it is important that these findings translate to human
biology. Human SH-SY5Y neuroblastoma cells can synthesize
DA, and are commonly used as a cellular model of PD. These cells
were exposed to conditioned media from S. venezuelae or S. coelicolor,
the latter of which did not cause significant neurodegeneration in
C. elegans neurons. Following 48 hours of exposure, cell viability
was measured by release of the intracellular enzyme, lactate
dehydrogenase (LDH). The extent of cell death was significantly
higher when SH-SY5Y cells were exposed to conditioned media
from S. venezuelae compared to S. coelicolor at most concentrations
tested (P,0.001; Fig. 7), until the amount of bacterial conditioned
Figure 4. The S. venezuelae factor does not enhance expression
of hsp-16, a small heat shock protein. LacZ expression is driven
from the hsp-16 promoter in an isogenic worm strain. X-gal staining was
used to examine expression of b-galactosidase (b-gal) in these animals.
A. hsp-16 expression occurs in response to specific stressors, such as
CdCl2. In contrast, hsp-16 expression is minimal within populations of C.
elegans exposed to S. venezuelae or E. coli conditioned media for six
days (*P,0.001; ANOVA). These data are represented as mean worms
positively stained with X-gal +/2 S.E.M. B. Worms exposed to the
proteasome inhibitor MG-132 for 6 days display minimal expression of
hsp-16, in contrast to the CdCl2 control (*P,0.001; Fisher Exact Test). C.
Photomicrographs depicting representative worms exposed to E. coli or
S. venezuelae conditioned medium, MG-132, or CdCl2. C. elegans
exposed to CdCl2 exhibited prominent hypodermal induction of b-gal
(arrow). Scale bar=100 mM.
doi:10.1371/journal.pone.0007227.g004
Figure 5. The UPR is not activated from exposure to the S.
venezuelae factor. Isogenic worms expressing GFP under control of
hsp-4 (homolog of mammalian BIP) were exposed to conditioned media
or MG-132 for six days and then examined for GFP expression. A.
Significantly higher levels of GFP fluorescence were observed within
populations of C. elegans exposed to the positive control, tunicamycin,
but not within populations animals of exposed to S. venezuelae or E. coli
conditioned media for six days (*P,0.001; ANOVA). These data are
represented as mean worms with increased GFP fluorescence +/2
S.E.M. B. Representative images of whole worms exposed to S.
venezuelae conditioned medium or tunicamycin. The worm exposed
to tunicamycin exhibited stronger fluorescence, particularly in the
region of the intestine proximal to the pharynx (arrow). Scale
bar=100 mM. C. MG-132, a proteasome inhibitor, activates the UPR at
a level that is non-significantly different from tunicamycin (P=0.653;
Fisher Exact Test). D. Representative images of magnified portions of C.
elegans exposed to the DMSO solvent (required for both MG-132 and
tunicamycin), MG-132, and tunicamycin. Arrows indicate region of
intestine proximal to the pharynx in all three animals. Scale bar=50 mM.
doi:10.1371/journal.pone.0007227.g005
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confirm that the S. venezuelae neurotoxic activity characterized in
the C. elegans model also has the capacity to cause degeneration of
human DA-producing neurons.
Characterization of the neurodegenerative factor
We have initiated the molecular characterization and isolation of
theS.venezuelaemetaboliteanditpossessesauniquesuiteofchemical
properties. We heated the S. venezuelae conditioned media at 100uC
for 30 minutes before treatment of C. elegans DA neurons. Boiling
had no effect on the neurodegenerative activity of the factor.
Specifically, 20% vs. 18% of worms displayed DA neurodegener-
ation after six days exposure to heat-treated and untreated factor,
respectively (Fig. 8A). Likewise, proteinase K digestion did not alter
the activity; 15% worms exhibited DA neurodegeneration after
exposure to the treated S. venezuelae factor (vs. 18% of worms
exposed to untreated factor; Fig. 8A). Thus, the S. venezuelae factor
appears to be a highly stable and robust bacterial metabolite,
characteristically distinct from known proteasome inhibitors.
We have begun chemical characterization of the neurotoxic
metabolite and have tested the product from each stage of the
purification process for DA neurodegeneration using C. elegans.
The S. venezuelae metabolite is soluble in water as demonstrated by
the presence/activity in conditioned medium and can be
partitioned from water into either ethyl acetate or dichlorometh-
ane (Fig. 8B), suggesting that the molecule has both lipophilic and
hydrophilic portions. When passed through a silica column to
further purify the factor, it partitions into the glyco- and polar lipid
fractions. That is, very little neurodegenerative activity was
recovered in the chloroform or first two acetone fractions;
however, the neurodegenerative factor was recovered in the last
two acetone and methanol fractions. The methanol fraction
showed a 6.5-fold increase in activity compared to E. coli
conditioned medium, again, suggesting a molecule with both
lipophilic and hydrophilic portions [31].
Lipopolysaccharide (LPS) is an endotoxin produced by gram-
negative bacteria that is associated with a reduced number of DA
neurons in rats when exposure occurs during the prenatal period
[32,33]. S. venezuelae, however, is a gram-positive bacterium and
these microbes are classified, in part, by an absence of LPS.
Therefore, taken together with the fact that LPS is insoluble in
dichloromethane, it is very unlikely that the S. venezuelae
neurodegenerative factor contains LPS.
To further purify this toxin, we used thin-layer chromatography
(TLC) of the methanol fraction and observed four distinct bands.
The bands were excised, eluted, and analyzed by gas chromatog-
raphy/mass spectrometry, which produced a chromatogram that
contained two related compounds. The peak shape of these
compounds is consistent with the polar nature of the molecule
and suggests an ionic functional group (possibly an underivatized
hydroxyl or amino functional group). Mass spectral analysis of these
compounds indicates a putative molecular weight of 180; each
spectrum contains a base peak of m/z 180, a second predominate
ion of m/z 70 and a fragmentation pattern indicative of a
hydrocarbon chain as a component of the parent molecule. Of
the five strong candidates for the molecular formula of the molecule
(i.e., molecular weight 180; C13H24,C 12H20O, C11H20N2,
C11H16O2,C 10H16N2O), the isotope pattern fits best with
C10H16N2O. Based on standard mass spectra analysis algorithms,
the factor likely contains an aromatic or heterocyclic ring and a
hydrocarbon chain (C5H11 or C6H13). While outside the scope of
this work, our continuing studies involve the isolation and structural
elucidation of the S. venezuelae neurodegenerative factor. Once we
have identified the chemical structure of the factor, this will assist
with a further understanding of the mechanism by which it is
causing neurodegeneration in C. elegans or SH-SY5Y cells, and will
facilitate development of in vivo mammalian models.
Discussion
Onset and progression of PD appears to converge at the
intersection between environmental influences, intrinsic DA
Figure 6. Ubiquitin-related degradation is impaired in C.
elegans DA neurons following exposure to the S. venezuelae
factor. A. Isogenic worms expressing a CFP::CL-1 degron fusion protein
within DA neurons were exposed to the proteasome inhibitor MG-132.
Mean pixel intensity of CFP fluorescence is significantly higher when the
proteasome in inactived (*P,0.05; Fisher Exact Test). B. CFP fluores-
cence is also significantly higher following exposure to S. venezuelae
conditioned medium when compared to E. coli medium (*P,0.05;
Fisher Exact Test). All data in this figure are represented as mean pixel
intensities [in arbitrary units (a.u.)] +/2 S.E.M.
doi:10.1371/journal.pone.0007227.g006
Figure 7. Human SH-SY5Y neuroblastoma cells exhibit cell
death following exposure to S. venezuelae conditioned medi-
um. Cell death was measured using LDH release; it was significantly
enhanced when cells were exposed to S. venezuelae in comparison to S.
coelicolor. This experiment was performed three times, in duplicate
(n=6) (*P,0.001; ANOVA). These data depict one independent
experiment that is representative of the others, whereby mean LDH
release is displayed as +/2 S. D.
doi:10.1371/journal.pone.0007227.g007
Neurotoxin from Streptomyces
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enhanced susceptibility to neurodegeneration over the course of
time. Increasing evidence supports deficits in, or inhibition of
protein degradation and clearance pathways by either genetic or
environmental factors as impacting neurodegeneration [9].
Indeed, a balance exists between proteasome function and
autophagy or lysosomal-based degradation as complementary
and compensatory mechanisms to mediate clearance of misfolded
proteins [34,35]. It is intriguing to consider that even mild toxin-
mediated UPS inhibition may combine with genetic deficit in
select autophagy genes to yield enhanced susceptibility to
neurodegeneration. Support for a ‘‘multiple hit’’ hypothesis for
induction of neurodegeneration in PD has recently come from an
elegant study indicating that increased cytosolic DA levels
influence neurotoxicity through generation of oxidized metabolites
that interact with a-synuclein, an effect that is blocked by calcium
channel blockers [36]. We previously showed that overexpression
of the C. elegans TH homolog, CAT-2, in nematode DA neurons
also led to increased neurodegeneration, an effect that was blocked
by 3-iodotyrosine treatment (13). Given the substantial neuropro-
tective impact of TH mutants on the toxicity caused by the
Streptomyces metabolite in C. elegans, it is interesting to speculate this
environmental factor may represent an added multifactoral
component in DA neurodegeneration.
Several prior studies have reported selective loss of DA neurons
after systemic administration of lactacystin or PSI to rodents
[10,37,38], but other investigators have had difficulty reproducing
these results [39,40]. Direct administration of either of these agents
into the brain, however, leads to a reliable and consistent
progressive degeneration of dopaminergic neurons [11,41]. It
has also recently been demonstrated that genetic depletion of the
26S proteasome subunit results in protein inclusions and
neurodegeneration in mice [42]. In this latter report, conditional
knockout in targeted brain neurons of mice clearly demonstrates a
role for proteasome function in neuronal homeostasis and survival.
This is significant to consider in the context of our findings
showing that our neurotoxic factor inhibits proteasome activity of
C. elegans DA neurons. Although a putative route of environmental
exposures to humans remains undefined, the small size and
stability of the bacterial metabolite we have identified suggests a
robust neurotoxic capacity. Additional work to define the
intracellular target(s) of this toxin will likely reveal more about
the mechanism underlying neurodegeneration.
While non-pathogenic bacteria have not been previously
implicated in PD-associated degeneration, an earlier report [43]
demonstrated that mice injected with Nocardia asteroides, a human
pathogen also of the order Actinomycetales, developed PD-like
symptoms and responded to levodopa treatment. Follow-up studies
showed that N. asteroides strain GUH-2 was neuroinvasive in the
brains of mice [44,45] and monkeys [46] and that infection resulted
in apoptotic death of DA neurons associated with proteasome
inhibition [47,48]. Another nocardial strain (GAM-5) has also been
shown to induce impaired movements and similar pathological
features in mice following sublethal infection [49]. Characterization
of culture filtrates from strain GUH-2 indicated that a non-lipid,
small molecular weight, secreted substance may be responsible for
DA-depleting effects [50]. While the chemical profile of the S.
venezualae neurotoxic factor is distinct from the nocardial metabolite,
taken together, these reports emphasize the potential impact of
bacterial exposures on neurodegeneration. The prevalence of PD
argues against pathogenic bacterial infection as a major contribu-
tory element in disease etiology. Nevertheless, in the context of our
findings with more common non-pathogenic bacterial species, a
prospective role for bacterial metabolites as environmental effectors
of neurotoxicity is understudied and should perhaps be revisited.
Moreover, the progressive nature of PD is reflected in the moderate
and age-associated gradated degeneration we observed in response
to the Streptomyces neurotoxic metabolite in C. elegans and warrants
further investigation in mammalian in vivo models. Importantly,
without knowing the precise identity of the factor(s) produced by
these bacteria, or the concentrations at which they are toxic to
humanscomparedtothoseappliedinthisreport,anycorrelationsto
PD pathogenesis are indirect and should be taken with caution, as
this remains to be resolved through future studies.
Figure 8. The S. venezuelae neurodegenerative factor is lipophilic and stable. A. Boiling conditioned media for 30 minutes or digestion with
proteinase K had no discernable effect on the neurodegenerative effect of the S. venezuelae factor. All data in this figure are represented as
percentage of mean worms exhibiting DA neurodegeneration. B. Partitioning with ethyl acetate (EtoAc) resulted in activity separation within the
organic but not the aqueous phase (compare ethyl acetate solvent only with aqueous portion). Further partitioning with dichloromethane (DcM) also
resulted in the activity separating in the lipophilic portion. In all cases, extracts were dried and resolubilized with ethyl acetate (solvent only control),
as it is non-lethal to C. elegans. The amount of DA neurodegeneration observed in the conditioned media control was lower than previously reported
because 34% less factor was used in each experiment (to ensure final ethyl acetate concentrations were below 1.5%).
doi:10.1371/journal.pone.0007227.g008
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questions regarding the source or extent of exposures. A rural
lifestyle, drinking well water, farming, and exposure to pesticides or
herbicides may all be risk factors for developing PD [3,4].
Systematic evaluation of occupational, domestic, and recreational
exposures to actinomycete-rich soil or adjacent well water sources
may reveal unforeseen correlates to PD. In this regard, surveys of
strain-specific effects, chronic vs. acute exposure paradigms, and
community-basedepidemiologicalanalysesareall requiredtobetter
define the impact of bacterial sources of neurotoxicity. Further
understanding the combined impact of such exposures with genetic
susceptibility will serve to better define therapeutic interventions.
Moreover, the prospect that bacterial metabolites could represent
putative biomarkers for disease susceptibility could serve to greatly
accelerate future diagnosis and refine risk assessment.
Materials and Methods
Nematode strains
Nematodes were maintained using standard procedures [51].
Strain UA30 (baEx30) consists of Pdat-1::GFP in dat-1 knockout
worms [RM2702 (ok157), a functional null] [13]. Additional
strains, as described below, were obtained from the Caenorhabditis
Genetics Center. These strains include N2 Bristol, SJ4005
[zcIs4(hsp-4::GFP)] (integrated Phsp-4::GFP strain) [28], CB1112
[cat-2(e1112)II] [23], BY200 vtIs1[Pdat-1::GFP + pRF4(rol-
6(su1006))] (an integrated Pdat-1::GFP strain) [13], EG1285 [lin-
15(n765ts);oxIn12] (an integrated unc-47::GFP strain) [19],
GR1366 mgIs42[tph-1::GFP + pRF4(rol-6(su1006))] (an integrated
Ptph-1::GFP strain) [18], DA1240 adIs1240[lin-15((+) eat-4::GFP) lin-
15B(n765) X] (an integrated Peat-4::GFP strain) [21], and NC300
wdIs5[(dpy-20(e1282) IV] (an integrated Punc-4::GFP strain) [20],
PC72 [48.1C and pRF4[rol-6(su1006))] (an integrated Phsp-4::lacZ
strain) [25].
For the generation of cat-2;P dat-1::GFP animals, Pdat-1::GFP
males were crossed to cat-2 hermaphrodites [23]. F1 hermaphro-
dites expressing GFP were allowed to self and F2 worms were
singled onto plates. The genomic region encompassing the cat-2
genetic lesion (stop codon) was sequenced from worm lines where
100% of the F3 generation expressed GFP (sequencing repeated
three additional times).
To construct Pdat-1::CFP::CL-1 transgenic worms, pPD133.48, a
CFP containing plasmid (gift from Andy Fire) was used as a
template to amplify CFP::CL-1 using a CFP specific forward
primer and a reverse primer that incorporated the last few
nucleotides of CFP and the entire CL-1 sequence [30] (sequences
available upon request). The CFP::CL-1 fusion was cloned into a
Gateway pDONR221 vector (Invitrogen) and then recombined
into pDEST-DAT1 [13]. 10 mg each of Pdat-1::CFP::CL-1 plasmid
DNA and an unc-119 rescuing vector (pDP#MM016B) [52] were
co-introduced into unc-119 worms by biolistic bombardment using
a Bio-Rad Biolistic PDS-1000/He particle delivery system [53]. A
rescued, stable (unc-119
+) line expressing CFP in DA neurons was
integrated using UV-irradiation in a Spectroline UV crosslinker at
254 nm at 200 mJ/cm
3. Multiple integrated lines were compared
and a representative line was examined for sensitivity to MG-132,
a proteasome inhibitor. This line [UA96 [baIn16; unc-119 (+)
Pdat-1::CFP-CL-1) unc-119 (ed3)] was out-crossed three times and
then used for all subsequent experiments.
C. elegans neurodegeneration assays
Three replicates of 30–40 worms were analyzed using a Nikon
E800 compound microscope with epi-fluorescence using an
Endow GFP filter cube (Chroma). Neurons were analyzed for
missing, shortened or blebbing processes, as well as rounding or
loss of cell bodies, as previously described [13]. Worms were
scored as having normal or wild-type neurons when none of these
abnormalities were present in any neurons. When neuron loss was
compared across treatments, degeneration of neurons in whole
worm populations was reported (e.g., DA neuron analysis).
However, when degeneration levels across different types of
neurons were compared to each other (for example, comparing
DA neurons to GABA neurons), percentages of degenerating
neurons were reported because varying numbers of neurons were
analyzed in the subclasses (21 ACh, 6 DA, 26 GABA, 23 Glut, and
6 5-HT neurons). Statistics were performed using ANOVA.
C. elegans exposure to proteasome inhibitors
L4 stage larvae of Pdat-1::GFP worms were grown on E. coli (strain
OP50) seeded NGM plates. MG-132 (EMD Biosciences) was
incorporatedinto themediaataconcentrationof50 mMinDMSO.
Worms were transferred to new plates containing fresh MG-132
every two days. DA neurons wereassayed for either degeneration or
pixel intensity changes (CFP::CL-1) at time points described in the
results section and compared to worms exposed to DMSO only.
C. elegans assay for generalized stress response
L4 stage Phsp-16::lacZ worms [25] were exposed to 25 ml/ml
conditioned media from either S. venezuelae or E. coli,5 0mM MG-
132, 0.2% DMSO as a solvent control, or 0.03 mg/ml CdCl2 [26]
for six days; animals were transferred to fresh plates (with
treatment) every two days. Approximately 300 Phsp-16::lacZ
worms/condition were fixed and stained using standard tech-
niques [54]. Fixed worms were scored for lacZ staining under a
Nikon compound microscope. Worms exhibiting X-gal stain were
scored as ‘‘stressed’’ while worms without staining were scored as
‘‘unstressed’’. Statistics were performed using ANOVA or Fisher
Exact Test, as described in the figure legend.
C. elegans ER stress assay
Approximately 300 worms per treatment (25 ml/ml conditioned
media from either S. venezuelae or E. coli,5 0mM MG-132, 0.2%
DMSO as a solvent control, or 0.03 mg/ml tunicamycin) were
assessed for upregulation of hsp-4 via GFP intensity analysis [28]. L4
animals were transferred to fresh plates (with treatment) every two
days. Worms were exposed to the treatments for 6 days before
analysis. Fluorescent levels were visually assessed using a Nikon
fluorescent dissecting scope. If worms expressed GFP throughout the
length of the intestine (where hsp-4 is expressed), and displayed
increased expression in the region of intestine proximal to the
pharynx, they were scored as having increased GFP fluorescence;
otherwise, when GFP levels were low (very little expression in the
intestine), they were scored as having basal GFP fluorescence.
Statistics were performed using ANOVA or Fisher Exact Test, as
described in the figure legend.
C. elegans in vivo degron analysis
L4 stage worms were exposed to 50 mM MG-132 in DMSO for
2 days before fluorescent analysis. We empirically determined that
2 days of exposure resulted in proteasome inhibition without
corresponding to DA neurodegeneration (see Fig. 1). Three
replicates of 30 Pdat-1::CFP::CL-1 worms were analyzed using a
Nikon E800 epi-fluorescent microscope equipped with a CFP filter
cube (Chroma). The average pixel intensity was measured for
every CEP neuron/worm using Metamorph software and these
values were compared between the solvent control and the
proteasome inhibitor treatment using the Fisher Exact Test.
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excretions or E.coli (control) conditioned media for 3 days before
analysis, as described above. Statistics to compare across all
treatments was performed using ANOVA.
Growth of Streptomyces spp
We examined three common soil bacteria from the genus
Streptomyces [S. venezuelae USDA-ARS ISP-5230, S. griseus USDA-
ARS B-2165, and S. coelicolor A3 (2)]. Spores were rehydrated at a
density of 1 610
6 in 1.2 L SYZ media. Because secondary
metabolites are excreted in response to different factors in the
environment [15], we tested different growth media to optimize
production of the neurodegenerative factor. Streptomyces species
were grown in nematode growth media (NGM), NGM with
0.15 M sorbitol, nutrient broth (NB), SYZ broth (soluble starch,
yeast extract, NZ amine) without XAD resin [16], or brain heart
infusion (BHI) medium for 2 weeks at 30uC. Cells were removed
by centrifugation at 10,000 x g in a Sorvall for 10 minutes and
supernatants were filtered through two filters, a 0.45 mm PES
vacuum filtration unit, followed by a 0.22 mm PES unit. After
filtration, conditioned media was dispensed into single use aliquots
and frozen for subsequent use. Exposures consisted of 25 ml/ml
conditioned media in each plate; L4 worms were transferred to
fresh plates (with treatment) every two days. After six days of
continuous exposure to the conditioned medium SYZ medium,
27% of worms displayed DA neurodegeneration, while only 6%,
4%, 7%, and 6% of worms exhibited DA neurodegeneration
following exposure to NGM, NGM with sorbitol, NB and BHI
media, respectively. Therefore, SYZ medium was used for all
assays.
C. elegans primary neuron cell culturing
Embryonic cell isolation and cell culture conditions were
performed as previously described [55]. After plating cells on culture
plates, cells were allowed to differentiate at 23uC for 48 hours before
bacterial conditioned media were administered (E. coli, S. venezuelae,
S.coelicolor,orS.griseus)atafinalconcentrationof0.5%withinthecell
culture media. The L-15 culture media with bacterial media was
replaced every two days. Cells were analyzed on a Leica Confocal
microscope. 50–90 cells per treatment condition were monitored
and scored for degeneration daily, for 7–9 days.
Mammalian cell culture methods
SH-SY5Y cells were maintained on Corning dishes in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum, 10 U/ml penicillin, 100 mg/ml
streptomycin. Cells were grown in a humidified atmosphere
containing 5% CO2. For treatment, approximately 150,000 cells
were plated in each well of 24-well plates. Twenty-four hours after
plating, SH-SY5Y cells were treated with various concentrations
(5–40%) of Streptomyces spp. conditioned media in serum-free
culture medium for 48 h. The release of LDH into the medium
was used as a quantitative measurement of cell viability and was
carried out as previously described [56]. The level of LDH release
following exposure to S. coelicolor conditioned media was used to
normalize the levels of LDH release observed following S. venezuelae
treatment to standardize the values. Experiments were performed
in triplicate and repeated three times. Statistics were performed
using ANOVA.
Solvent extraction of the conditioned media
Filtered culture broths were extracted with an equal volume of
ethyl acetate or dichloromethane using a separatory funnel. The
mixture was gently shaken and the phases allowed to separate. The
ethyl acetate or dichloromethane layer was collected and the
process was repeated two more times. The organic phases were
pooled and dried [31]. The dried extract were weighed and
resuspended (3 mg/ml) in ethyl acetate for worm DA neurode-
generation assays, which were performed blinded. In these assays,
15 ml/ml of partially purified S. venezuelae medium or 15 ml/ml
ethyl acetate (solvent control) was added to Petri dishes for a final
concentration of 45 mg/ml in the agar nematode media. L4 worms
were exposed to fresh bacterial extract or solvent every two days
and DA neuron analysis was performed after six days of exposure.
Chemical characterization of S. venezuelae factor
Two different treatments were used to examine the stability of
the S. venezuelae factor: 1) conditioned medium was boiled for 30
minutes, and 2) conditioned medium was exposed to 0.5 mg/mL
proteinase K for 1 hr at 65uC prior to heat inactivation of the
enzyme at 95uC for 10 minutes. Both forms of treated S. venezuelae
conditioned medium were added to NGM plates and L4 stage
worms were grown in the presence of the factor for six days. DA
neurodegeneration in C. elegans was assayed as described
previously. Untreated S. venezuelae conditioned medium exposure
was used as a positive control.
Silicic acid column chromatography was used to further
partition the dichloromethane soluble fraction. A 2.5 cm diameter
column packed with 16 g of silica gel (Fisher Scientific, 70–
230 mm and 60 A, total volume 18 cm
3) was used for separation.
A flow rate of ,5 ml/min was used for elution. Dried extracts of
filtered culture broths were dissolved in a minimum volume of
dichloromethane and added to the column. Fractions were eluted
from the column in 10, 4610, and 10 column volumes of
chloroform, acetone, and methanol, respectively, yielding a total of
six fractions. Fractions were dissolved in ethyl acetate at 1 mg/ml
and tested for neurodegenerative activity in C. elegans as described
above, with the highest levels being detected in the methanol
fraction (which was only partially soluble in ethyl acetate). This
fraction was loaded onto a silica TLC plate and separated using a
chloroform:acetone:methanol:acetic acid:water (10:4:2:2:1) solvent
mixture. After the solvent had traversed 95% of the plate height,
the plate was removed, dried, and the position of the compound
bands determined. Four discrete bands were observed; each was
removed from the plate and the compounds present eluted from
the silica with methanol. The solvent was dried and the sample
resuspended in chloroform and injected into an Agilent 6890 gas
chromatograph fitted with a DB-5 fused-silica column and an
Agilent 5893 Mass Selective Detector operated in scan mode. Ion
impact spectra of individual compounds were generated and
interpreted using standard organic chemical concepts.
Acknowledgments
We wish to acknowledge the cooperative spirit of all Caldwell Lab
members and the UA/UAB Parkinson Disease Research Forum. Special
thanks to Shusei Hamamichi for cloning the CFP-CL-1 vector, as well as
Laura Berkowitz, Courtney Haycraft, Perry Churchill, and Anthony
Nicholas for helpful discussions.
Author Contributions
Conceived and designed the experiments: KAC MLT JA TWH JC RHF
QR DGS JBO GAC. Performed the experiments: KAC MLT JA TWH JC
SBM JEB SMD QR PJW JBO. Analyzed the data: KAC MLT JA TWH
JC RHF QR PJW DGS JBO GAC. Contributed reagents/materials/
analysis tools: MLT JA TWH JC QR JBO. Wrote the paper: KAC TWH
RHF DGS JBO GAC.
Neurotoxin from Streptomyces
PLoS ONE | www.plosone.org 9 October 2009 | Volume 4 | Issue 10 | e7227References
1. Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in
Parkinson’s disease. Science 302: 819–822.
2. Tanner CM (2003) Is the cause of Parkinson’s disease environmental or
hereditary? Evidence from twin studies. Adv Neurol 91: 133–142.
3. Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS (2001) Environmental
risk factors and Parkinson’s disease: a metaanalysis. Environ Res 86: 122–127.
4. Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B (2009) Parkinson’s
disease and residential exposure to maneb and paraquat from applications in the
central valley of California. Am J Epidemiol 169: 919: 926.
5. Tanner CM (1992) Occupational and environmental causes of parkinsonism.
Occup Med 7: 503–513.
6. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ (1998) The
risk of Parkinson’s disease with exposure to pesticides, farming, well water, and
rural living. Neurol 50: 1346–1350.
7. Firestone JA, Smith-Weller T, Franklin G, Swanson P, Longstreth WT Jr, et al.
(2005) Pesticides and risk of Parkinson disease: a population-based case-control
study. Arch Neurol 62: 91–95.
8. Janssen PH (2006) Identifying the dominant soil bacterial taxa in libraries of 16S
rRNA and 16S rRNA genes. Appl Environ Microbiol 72: 1719–1728.
9. Cook C, Petrucelli L (2009) A critical evaluation of the ubiquitin–proteasome
system in Parkinson’s disease. Biochim Biophys Acta 1792: 664–675.
10. McNaught KS, Perl DP, Brownell AL, Olanow CW (2004) Systemic exposure to
proteasome inhibitors causes a progressive model of Parkinson’s disease. Ann
Neurol 56: 149–162.
11. Sun F, Anantharam V, Zhang D, Latchoumycandane C, Kanthasamy A, et al.
(2006) Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell
culture and animal models. NeuroTox 27: 807–815.
12. Nass R, Hall DH, Miller DM, Blakely RD (2002) Neurotoxin-induced
degeneration of dopamine neurons in Caenorhabditis elegans. Proc Natl Acad
Sci U S A 99: 3264–3269.
13. Cao S, Gelwix CC, Caldwell KA, Caldwell GA (2005) Torsin-mediated
protection from cellular stress in the dopaminergic neurons of Caenorhabditis
elegans. J Neurosci 25: 3801–3812.
14. Zhang Y, Lu H, Bargmann CI (2005) Pathogenic bacteria induce aversive
olfactory learning in Caenorhabditis elegans. Nature 438: 179–184.
15. Deimain AL, Fang A (2000) The Natural Functions of Secondary metabolites.
In: Scheper T, ed (2000) Advances in Biochemical Engineering/Biotechnology.
Berlin/Heidelberg: Springer. pp 1–39.
16. Park YC, Gunasekera SP, Lopez JV, McCarthy PJ, Wright AE (2006)
Metabolites from the marine-derived fungus Chromocleista sp. isolated from a
deep-water sediment sample collected in the Gulf of Mexico. J Natural Products
69: 580–584.
17. Sawin ER, Ranganathan R, Horvitz HR (2000) C. elegans locomotory rate is
modulated by the environment through a dopaminergic pathway and by
experience through a serotonergic pathway. Neuron 26: 619–631.
18. Sze JY, Victor M, Loer C, Shi Y, Ruvkun G (2000) Food and metabolic
signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature
403: 560–564.
19. McIntire SL, Reimer R, Schuske K, Edwards RH, Jorgensen E (1997)
Identification and characterization of the vesicular GABA transporter. Nature
389: 870–876.
20. Lickteig KM, Duerr JS, Frisby DL, Hall DH, Rand JB, et al. (2001) Regulation
of Neurotransmitter Vesicles by the Homeodomain Protein UNC-4 and Its
Transcriptional Corepressor UNC-37/Groucho in Caenorhabditis elegans Cholin-
ergic Motor Neurons. J Neurosci 21: 2001–2014.
21. Lee RY, Sawin ER, Chalfie M, Horvitz HR, Avery L (1999) EAT-4, a homolog
of a mammalian sodium-dependent inorganic phosphate cotransporter, is
necessary for glutamatergic neurotransmission in Caenorhabditis elegans. J Neurosci
19: 159–167.
22. Carvelli L, McDonald PW, Blakely RD, DeFelice LJ (2004) Dopamine
transporters depolarize neurons by a channel mechanism. Proc Natl Acad
Sci U S A 101: 16046–16051.
23. Sulston J, Dew M, Brenner S (1975) Dopaminergic neurons in the nematode
Caenorhabditis elegans. J Comp Neur 163: 215–226.
24. Sanyal S, Wintle RF, Kindt KS, Nuttley WM, Arvan R, et al. (2004) Dopamine
modulates the plasticity of mechanosensory responses in Caenorhabditis elegans.
EMBO J 23: 473–482.
25. Stringham EG, Candido EPM (1994) Transgenic hsp16-lacZ strains of the soil
nematode Caenorhabditis elegans as biological monitor of environmental stress.
Environ Tox Chem 13: 1211–1220.
26. Jones D, Stringham EG, Babich SL, Candido EP (1996) Transgenic strains of
the nematode C. elegans in biomonitoring and toxicology: effects of captan and
related compounds on the stress response. Toxicology 109: 119–127.
27. Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, et al. (2002)
Endoplasmic reticulum stress and the unfolded protein response in cellular
models of Parkinson’s disease. J Neurosci 22: 10690–10698.
28. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, et al. (2002) IRE1 couples
endoplasmic reticulum load to secretory capacity by processing the XBP-1
mRNA. Nature 415: 92–96.
29. Bush KT, Goldberg AL, Nigam SK (1997) Proteasome inhibition leads to a
heat-shock response, induction of endoplasmic reticulum chaperones and
thermotolerance. J Biol Chem 272: 9086–9092.
30. Bence NF, Sampat RM, Kopito RR (2001) Impairment of the ubiquitin-
proteasome system by protein aggregation. Science 292: 1552–1555.
31. Gailliot FP (1998) Initial extraction and product capture. In: Cannell RJP, ed.
Natural Products Isolation. Totawa, New Jersey: Humana Press Inc. pp 53–89.
32. Ling Z, Gayle DA, Ma SY, Lipton JW, Tong CW, et al. (2002) In utero bacterial
endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal
rat midbrain. Mov Disord 17: 116–124.
33. Ling ZD, Chang Q, Lipton JW, Tong CW, Landers TM, et al. (2004) Combined
toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopa-
mine in the adult rat midbrain. Neuroscience 124: 619–628.
34. Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, et al. (2007) HDAC6
rescues neurodegeneration and provides an essential link between autophagy
and the UPS. Nature 447: 859–863.
35. Nedelsky NB, Todd PK, Taylor JP (2008) Autophagy and the ubiquitin-
proteasome system: collaborators in neuroprotection. Biochim Biophys Acta
1782: 691–699.
36. Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, et al. (2009)
Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes
selective death of substantia nigra neurons. Neuron 62: 218–229.
37. Zeng BY, Bukhatwa S, Hikima A, Rose S, Jenner P (2006) Reproducible nigral
cell loss after systemic proteasomal inhibitor administration to rats. Ann Neurol
60: 248–252.
38. Schapira AH, Cleeter MW, Muddle JR, Workman JM, Cooper RH, et al. (2006)
Proteasomal inhbition causes loss of nigral tyrosine hydroxlase neurons. Ann
Neurol 60: 253–255.
39. Kordower JH, Kanaan NM, Chu Y, Sursh Babu R, Stansell III J, et al. (2006)
Failure of proteasome inhibitor administration to provide a model of Parkinson’s
disease in rats and monkeys. Ann Neurol 60: 264–268.
40. Manning-Bog AB, Reaney SH, Chou VP, Johnston AL, McCormack J, et al.
(2006) Lack of nigrostriatal pathology in a rat model of proteasome inhibition.
Ann Neurol 60: 256–270.
41. Li X, Du Y, Fan X, Yang D, Luo G, et al. (2008) c-Jun N-terminal kinase
mediates lactacystin-induced dopamine neuron degeneration. J Neuropathol
Exp Neurol 67: 933–944.
42. Bedford L, Hay D, Devoy A, Paine S, Powe DG, et al. (2008) Depletion of 26S
proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like
inclusions resembling human pale bodies. J Neurosci 28: 8189–8198.
43. Kohbata S, Beaman BL (1991) L-Dopa-responsive movement disorder caused
by Nocardia asteroides localized in the brains of mice. Infect Immun 59: 181–191.
44. Ogata SA, Beaman BL (1992) Adherence of Nocardia asteroides within the murine
brain. Infect Immun 60: 1800–1805.
45. Ogata SA, Beaman BL (1992) Site-specific growth of Nocardia asteroides in the
murine brain. Infect Immun 60: 3262–3267.
46. Chapman G, Beaman BL, Loeffler DA, Camp DM, Domino EF, et al. (2003) In
situ hybridization for detection of nocardial 16S rRNA: reactivity within
intracellular inclusions in experimentally infected cynomolgus monkeys–and in
Lewy body-containing human brain specimens. Exp Neurol 184: 715–725.
47. Tam S, Barry DP, Beaman L, Beaman BL (2002) Neuroinvasive Nocardia
asteroides GUH-2 induces apoptosis in the substantia nigra in vivo and
dopaminergic cells in vitro. Exp Neurol 107: 453–460.
48. Barry DP, Beaman BL (2006) Modulation of eukaryotic cells apoptosis by
members of the bacterial order Actinomycetales. Apoptosis 11: 1695–1707.
49. Dı ´az-Corrales FJ, Colasante C, Contreras Q, Puig M, Serrano JA, et al. (2004)
Nocardia otitidiscaviarum (GAM-5) induces parkinsonian-like alterations in mouse.
Braz J Med Biol Res 37: 539–548.
50. Loeffler DA, Camp DM, Qu S, Beaman BL, LeWitt PA (2004) Characterization
of dopamine-depleting activity of Nocardia asteroides strain GUH-2 culture filtrate
on PC12 cells. Microb Pathog 37: 73–85.
51. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71–94.
52. Maduro M, Pilgrim D (1995) Identification and cloning of unc-119, a gene
expressed in the Caenorhabditis elegans nervous system. Genetics 141: 977–988.
53. Praitis V, Casey E, Collar D, Austin J (2001) Creation of low-copy integrated
transgenic lines in Caenorhabditis elegans. Genetics 157: 1217–1226.
54. Caldwell GA, Williams SN, Caldwell KA (2006) Integrated Genomics: A
Discovery-Based Laboratory Course. Chichester: John Wiley. pp 17–21.
55. Strange K, Christensen M, Morrison R (2007) Primary culture of Caenorhabditis
elegans developing embryo cells for electrophysiological, cell biological and
molecular studies. Nature Protocols 2: 1003–1012.
56. Decker T, Lohmann-Matthes ML (1988) A quick and simple method for the
quantitation of lactate dehydrogenase release in measurements of cellular
cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115:
61–69.
Neurotoxin from Streptomyces
PLoS ONE | www.plosone.org 10 October 2009 | Volume 4 | Issue 10 | e7227